Wilson Guzman

Wilson Guzman has a diverse work experience in the field of scientific research. Wilson began their career at EMD Lexigen Pharmacetic in 2004, where they worked as a Laboratory Support/ Animal Care professional for six years. In 2010, Wilson joined EMD Serono, Inc. as a Research Associate I, and later Research Associate II, focusing on ImmunoOncology. In this role, they designed and conducted in vivo pharmacology studies in murine tumor models, optimized the dose and schedule for novel agents, and utilized immune readouts for early clinical development. Wilson also contributed to the authorship of regulatory submission documents and scientific publications. In 2015, they joined Compass Therapeutics LLC as a Principal Associate Scientist, where they continued their scientific research. Most recently, Wilson joined Akrevia Therapeutics, Inc. in 2019 as a Scientist.

Wilson Guzman attended Lawrence High School from 1998 to 2001, where they completed their high school education. During the same period, they also attended Merrimack College and pursued a field of study in General Studies. After completing high school, from 2001 to 2003, Wilson Guzman enrolled in Northern Essex Community College to pursue a degree in Business Transfer with a focus on Business/Managerial Economics.